EntreMed, Inc. (EntreMed) is a clinical-stage pharmaceutical company focused on developing multi-mechanism oncology drugs that target disease cells and the blood vessels that nourish them. The Company focused on developing drugs that are safe and convenient, and provide the potential for... more

Pro-Pharmaceuticals, Inc. is a development stage company engaged in the discovery, development, and commercialization of first-in-class, targeted therapeutic compounds for advanced treatment of cancer, liver, microbial and inflammatory diseases. The Company focuses on the development of a... more

AlphaRx is developing several drug products in the therapeutic categories of Osteoarthritis and Infectious Disease. AlphaRx intends to file IND and NDA submissions with the FDA (when necessary) and license these products to other pharmaceutical companies for worldwide commercialization. ... more

Pharmasset, Inc. (Pharmasset) is a clinical-stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections. The Company's primary focus is on the development of oral therapeutics for the treatment of human immunodeficiency virus... more

At ActivBiotics, we are dedicated to achieving success through leadership and the unrelenting pursuit of scientific breakthrough. Our greatest asset is our people, and we are bringing together the brightest and most talented scientific professionals to the ActivBiotics team. If you are an... more

Kalypsys is a clinical stage pharmaceutical company that is advancing the way drugs are discovered and developed. We seamlessly integrate our capabilities in drug discovery, medicinal chemistry and translational medicine with proprietary automated technologies to discover and develop high... more

Dynogen is a clinical stage biopharmaceutical company developing more effective treatments for gastrointestinal (GI) and genitourinary (GU) disorders. The Company has an advanced pipeline of clinical development programs focused on attractive and untapped markets in disease areas that... more

Protarga is a clinical stage pharmaceutical company that is developing Targaceutical® drugs for new medical therapies. The Company's strategic priority is the development of innovative new treatments for cancer, infectious diseases and CNS disorders.

DMI BioSciences, Inc. (DMI) is a privately-held clinical stage pharmaceutical company with a global strategy to discover and develop new therapeutic options to treat disease. Our most advanced drugs address significant unmet needs in men's health, ophthalmology and oncology with three... more

Humanetics Corporation is a clinical-stage pharmaceutical company engaged in accelerated discovery, development and commercialization of proprietary drugs in markets with urgent and unmet needs. With a focus on non-synthetic, self-administered, bioactive compounds for disease prevention... more

NovaCal Pharmaceuticals is a clinical-stage pharmaceutical company developing a new class of compounds: The AganocideÔ compounds. They are novel, safe and effective non-antibiotic antimicrobial molecules. Our goals are two-fold: 1) to reduce the threat of hospital-based infections, and 2)... more

Royalmount Pharma is an emerging clinical stage pharmaceutical company focused on developing and commercializing innovative and affordable medicines to address underserved demand in various pharmaceutical markets. The company improves the formulation and delivery of pharmaceutical... more

American BioHealth Group LLC, is a clinical stage pharmaceutical company located in San Diego, California. Our target market is individuals wishing to help prevent acute hearing loss or tinnitus (ringing in the ears), those seeking aids in treatment immediately after acute hearing loss or... more

LifeTimeÔ Pharmaceuticals, Inc., a clinical stage pharmaceutical company, is dedicated to clinical testing and developing non-toxic small molecules that regulate the bone marrow, monocytes and lymphocytes. LifeTimeÔ focuses on the development of drugs that are safe enough for long-term,... more

Essentialis is focused on the development of new therapeutic products that address the underlying pathobiology of metabolic disease. Products targeted in this manner offer the potential to be both more effective and safer.

Melior Discovery is dedicated to uncovering new therapeutic applications for partners' existing drugs. By utilizing the unique and highly efficient theraTRACESM indications discovery platform, Melior can systematically study a single compound in multiple in vivo models, thereby evaluating... more

Cortria is a clinical-stage pharmaceutical company focused on developing safe and well-tolerated medicines to fight cardiovascular disease.

Alacrity Biosciences is committed to bringing to market unique and proprietary products to treat ophthalmic diseases. Our approach is to develop compounds with unique mechanisms of action to fulfill unmet needs and/or compliment existing therapeutic modalities to optimize patient... more